Canadian Center for Vaccinology | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness	Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease	Recruiting	Phase 1	2026-08-27		NCT07305207
Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine	Bacterial Infections and Mycoses, Infections, Pasteurellaceae Infections, bacterial infectious disease, gram-negative bacterial infections, haemophilus infectious disease	Active, not recruiting	Phase 2	2026-08-03		NCT07743008
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Corynebacterium Infections, Infections, bacterial infectious disease, diphtheria, gram-positive bacterial infections	Recruiting	Phase 4	2026-06-16		NCT07097012
Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies	Infections, Vaccine-Preventable Diseases	Recruiting	Not applicable	2026-03-19		NCT06489964
Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart	Infections, RNA Virus Infections, avian influenza, bird disease, influenza, non-human animal disease, viral infectious disease	Active, not recruiting	Phase 4	2026-01-16		NCT07275060
Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 2	2025-03-18		NCT04894435